Biotechnology - Mergers & Acquisitions, Biotechnology

Filter

Popular Filters

1 to 25 of 269 results

Ipsen pays 6 million euros for option to acquire Canbex

24-02-2015

French drugmaker Ipsen today announced that UK-based biotech firm Canbex Therapeutics has granted an…

BiotechnologyCanbex TherapeuticsIpsenMergers & AcquisitionsNeurologicalVSN16R

Sosei acquires Heptares Therapeutics for up to $400 million

Sosei acquires Heptares Therapeutics for up to $400 million

23-02-2015

Japanese drugmaker Sosei Group says it has acquired Heptares Therapeutics, a clinical-stage private UK-based…

BiotechnologyHeptares TherapeuticsMergers & AcquisitionsNeurologicalRare diseasesSosei

Intrexon to acquire Belgium's ActoGeniX, bringing new generation of orally-delivered biotherapeutics

13-02-2015

US synthetic biology focussed US firm Intrexon has entered into a definitive agreement to acquire ActoGeniX,…

ActoGeniXBiotechnologyIntrexonMergers & Acquisitions

No new bidders emerge for Dendreon, so Valeant gets Provenge

No new bidders emerge for Dendreon, so Valeant gets Provenge

11-02-2015

US biotech firm Dendreon revealed yesterday that the bid deadline provided by the Court-approved bidding…

BiotechnologyDendreonMergers & AcquisitionsOncologyProvengeValeant Pharmaceuticals International

New biotech start-up OptiKira created by BioMotiv

New biotech start-up OptiKira created by BioMotiv

02-02-2015

USA-based BioMotiv, a drug development accelerator associated with The Harrington Project, the University…

BioMotivBiotechnologyDiabetesMergers & AcquisitionsOptiKiraRare diseasesResearch

Valeant to serve as “stalking horse bidder” in court-supervised Dendreon sales process

30-01-2015

US biotech firm Dendreon says it has reached an agreement with Canada’s Valeant Pharmaceuticals International…

BiotechnologyDendreonMergers & AcquisitionsOncologyProvengeValeant Pharmaceuticals International

RegeneRx links with G-treeBNT to develop RGN-259 in the USA

RegeneRx links with G-treeBNT to develop RGN-259 in the USA

29-01-2015

US biotech firm RegeneRx Biopharmaceuticals has entered into agreements with South Korea-based G-treeBNT…

BiotechnologyG-treeBNTLicensingMergers & AcquisitionsOphthalmicsRegeneRxRGN-259USA

Dendreon extends deadline for qualified bids for the company

Dendreon extends deadline for qualified bids for the company

28-01-2015

US biotech firm Dendreon said yesterday that it would be extending the bid deadline for interested parties…

BiotechnologyDendreonMergers & AcquisitionsOncologyProvenge

3SBio acquires Italy’s Sirton Pharmaceuticals

27-01-2015

Chinese biotech firm 3SBio today revealed that last month it acquired the entire share capital of Italy-based…

3SBioBiotechnologyEuropeMergers & AcquisitionsSirton Pharmaceuticals

Innovation and confidence at JP Morgan conference, says Edison analyst

26-01-2015

The atmosphere at this year's annual JPMorgan Conference in San Francisco was understandably buoyant,…

BiotechnologyFinancialMergers & AcquisitionsResearch

Motif Biosciences agrees to merge with company holding IP to potential MRSA antibiotic

Motif Biosciences agrees to merge with company holding IP to potential MRSA antibiotic

19-01-2015

Motif Biosciences, a partner of life science business developer Amphion Innovations, has entered into…

Amphion InnovationsAntibiotics and Infectious diseasesBiotechnologyMergers & AcquisitionsMotif BiosciencesMRSA antibioticUSA

Roche continues spending spree, with acquisition of French biotech firm Trophos

Roche continues spending spree, with acquisition of French biotech firm Trophos

16-01-2015

Continuing its recent spate of deal-making, Swiss pharma giant Roche has agreed to acquire Trophos, a…

BiotechnologyMergers & AcquisitionsolesoximeRare diseasesRocheSwitzerlandTrophos

Low dollar tipped to stimulate biotech investment in Australia

15-01-2015

Analyst commentary suggests the devaluation of the Australian dollar during 2014, has left biotech in…

ActinogenAustraliaBenitec BiopharmaBiotechnologyFinancialMergers & AcquisitionsSirtex Medical

Biogen Idec to acquire Convergence Pharma in potential $675 million deal

12-01-2015

US biotech major Biogen Idec has agreed to acquire independent UK-based Convergence Pharmaceuticals,…

Biogen IdecBiotechnologyCNV-1014802Convergence PharmaceuticalsMergers & AcquisitionsNeurologicalPainUnited Kingdom

Qiagen acquires unit of Enzymatics and agrees partnership with ArcherDX

Qiagen acquires unit of Enzymatics and agrees partnership with ArcherDX

12-01-2015

Netherlands-based company Qiagen has acquired the Enzyme Solutions Unit of privately-held US company…

ArcherDXBiotechnologyEnzymaticsGeneticsMergers & AcquisitionsNetherlandsQiagen

Shire to spend $5.2 billion to buy NPS Pharma

Shire to spend $5.2 billion to buy NPS Pharma

12-01-2015

Recently jilted Ireland-headquartered Shire says it is to acquire NPS Pharmaceuticals, confirming recent…

BiotechnologyEuropeGattexMergers & AcquisitionsNatparaNPS PharmaceuticalsRare diseasesRevestiveShire

Horizon Discovery agrees to acquire Haplogen Genomics in $9 million deal

Horizon Discovery agrees to acquire Haplogen Genomics in $9 million deal

08-01-2015

Life science research tool supplier Horizon Discovery Group has agreed to acquire Haplogen Genomics,…

BiotechnologyEvent horizonHaplogen GenomicsHorizon Discovery GroupMergers & Acquisitions

Gilead acquires Phenex program for NASH and other liver diseases

Gilead acquires Phenex program for NASH and other liver diseases

06-01-2015

US biotech major Gilead Sciences and privately-held German biotech firm Phenex Pharmaceuticals have signed…

AvogenxBiotechnologyGilead SciencesIntercept PharmaceuticalsMergers & AcquisitionsNephrology and HepatologyPhenex Pharmaceuticals

Cardio3 BioSciences acquires Celdara’s OnCyte division

Cardio3 BioSciences acquires Celdara’s OnCyte division

06-01-2015

Belgian biotech firmCardio3 BioSciences has acquired OnCyte, the oncology division of privately-held…

BiotechnologyCardio3 BioSciencesCeldara MedicalMergers & AcquisitionsOncologyOnCyte

Janssen partners with MacroGenics in up to $625 million deal

Janssen partners with MacroGenics in up to $625 million deal

23-12-2014

Shares of US biotech firm MacroGenics rocketed 11.7% to a 10-month high of $38.58 yesterday, on the news…

BiotechnologyGlobalJanssen BiotechJohnson & JohnsonLicensingMacroGenicsMergers & AcquisitionsMGD011Oncology

Bina Technologies is acquired by Roche

20-12-2014

Swiss pharma giant Roche has acquired Bina Technologies, a privately held company based in Redwood City,…

Bina TechnologiesBiotechnologyMergers & AcquisitionsRoche

Merck & Co in up to $375 million deal to acquire OncoEthix

Merck & Co in up to $375 million deal to acquire OncoEthix

19-12-2014

US pharma giant Merck & Co said yesterday that it has acquired, through a subsidiary, Swiss-based privately…

BiotechnologyMerck & CoMergers & AcquisitionsOncoEthixOncologyOTX015

Roche to acquire Austrian next-generation antibody firm Dutalys

Roche to acquire Austrian next-generation antibody firm Dutalys

19-12-2014

Swiss pharma giant Roche has agreed to acquire Dutalys, a privately held biotechnology company based…

BiotechnologyDutalysDutaMabMergers & AcquisitionsOncologyRoche

NetScientific invests in PDS Biotechnology

NetScientific invests in PDS Biotechnology

15-12-2014

UK-based life sciences investor NetScientific has made an undisclosed investment in privately-held US…

Antibiotics and Infectious diseasesBiotechnologyMergers & AcquisitionsNetScientificOncologyPDS BiotechnologyUK

1 to 25 of 269 results

Back to top